TIP30 regulates apoptosis-related genes in its apoptotic signal transduction pathway

World Journal of Gastroenterology

Volumn 11, Issue 2, 2005, Pages 221-227

  Shi, Mei ^a,b   Zhang, Xia ^c   Wang, Ping ^b   Zhang, Hong Wei ^a   Zhang, Bai He ^b   Wu, Meng Chao ^b  

^a SHANDONG UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c FUZHOU GENERAL HOSPITAL   (China)

Author keywords

Apoptosis; Hepatoblastoma; Signal transduction; TIP30

Indexed keywords

ADENOVIRUS VECTOR; DNA; DNA FRAGMENT; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; PROTEIN BAX; PROTEIN BCL XL; PROTEIN P53; PROTEIN SERINE THREONINE KINASE; PROTEIN TIP30; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER REGRESSION; CANCER SUSCEPTIBILITY; CELL ASSAY; CELL COUNT; CELL DEATH; CELL STRAIN HEPG2; CELL VIABILITY; CONTROLLED STUDY; CYTOCHEMISTRY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC REGULATION; HEPATOBLASTOMA; HUMAN; HUMAN CELL; HYPOTHESIS; NICK END LABELING; PROTEIN EXPRESSION; SENSITIZATION; SIGNAL TRANSDUCTION; TIME; TREATMENT OUTCOME; UPREGULATION; WESTERN BLOTTING; WILD TYPE;

EID: 12344317887     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i2.221     Document Type: Article

References (36)

1. Xiao H, Tao Y, Greenblatt J, Roeder RG. A cofator, TIP30, specifically enhances HIV-1 Tat-activated transcription. Proc Natl Acad Sci USA 1998; 95: 2146-2151
2. Baker ME, Yan L, Pear MR. Three-dimensional model of human TIP30, a coactivator for HIV-1 Tat-activated transcription, and CC3, a protein associated with metastasis suppression. Cell Mol Life Sci 2000; 57: 851-858
3. Chene P. Inhibition of the p53-MDM2 interaction: targeting a protein-protein interface. Mol Cancer Res 2004; 2 20-28
4. Batinac T, Gruber F, Lipozencic J, Zamolo-Koncar G, Stasic A, Brajac I. Protein p53-structure, function, and possible therapeutic implications. Acta Dermatovenerol Croat 2003; 11: 225-230
5. Mirza A, Wu Q, Wang L, McClanahan T, Bishop WR, Gheyas F, Ding W, Hutchins B, Hockenberry T, Kirschmeier P, Greene JR, Liu S. Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression. Oncogene 2003; 22: 3645-3654
6. Courageot MP, Catteau A, Despres P. Mechanisms of dengue virus-induced cell death. Adv Virus Res 2003; 60: 157-186
7. Hayward RL, Macpherson JS, Cummings J, Monia BP, Smyth JF, Jodrell DI. Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: Genetic evidence for specificity of the antisense effect. Mol Cancer Ther 2004; 3: 169-178
8. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M, Green DR. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 2004; 13: 1010-1014
9. Groeger AM, Esposito V, De Luca A, Cassandro R, Tonini G, Ambrogi V, Baldi F, Goldfarb R, Mineo TC, Baldi A, Wolner E. Prognostic value of immunohistochemical expression of p53, bax, Bcl-2 and Bcl-xL in resected non-small-cell lung cancers. Histopathology 2004; 44: 54-63
10. Feng WY, Liu FT, Patwari Y, Agrawal SG, Newland AC, Jia L. BH3-domain mimetic compound BH3I-2′ induces rapid damage to the inner mitochondrial membrane prior to the cytochrome c release from mitochondria. Br J Haematol 2003; 121: 332-340
11. Moreau C, Cartron PF, Hunt A, Meflah K, Green DR, Evan G, Vallette FM, Juin P. Minimal BH3 peptides promote cell death by antagonizing anti-apoptotic proteins. J Biol Chem 2003; 278: 19426-19435
12. Dimitrakakis C, Konstadoulakis M, Messaris E, Kymionis G, Karayannis M, Panoussopoulos D, Michalas S, Androulakis G. Molecular markers in breast cancer: can we use c-erbB-2, p53, bcl-2 and bax gene expression as prognostic factors? Breast 2002; 11: 279-285
13. Jiang MC, Yen HF. Differential regulation of p53, c-myc,Bcl-2 and Bax protein expression during apoptosis induced by wildly divergent stimuli in human hepatoblastoma cells. Oncogene 1996; 22: 609
14. Shi M, Wang FS, Wu ZZ. Synergetic anticancer effect of combined quercetin and recombinant adenoviral vector expressing human wild-type p53, GM-CSF and B7-1 genes on hepatocellular carcinoma cells in vitro. World J Gastroentero 12003; 9: 73-78
15. Lee SH, DeJong J. Microsomal GST-I: genomic organization, expression, and alternative splicing of the human gene. Biochim Biophys Acta 1999; 1446: 389-396
16. Sherr CJ. Tumor surveillance via the ARF-p53 pathway. Genes Dev 1998; 12: 2984-2991
17. Xiao H, Palhan V, Yang Y, Robert RG. TIP30 has an intrinsic kinase activity required for up-regulation of a subset of apoptotic genes. EMBO 2000; 19: 956-963
18. Mocanu MM, Yellon DM. p53 down-regulation: a new molecular mechanism involved in ischaemic preconditioning. FEBS Lett 2003; 555: 302-306
19. Avantaggiati ML, Ogryzko V, Gardner K, Giordano A, Levine AS, Kelly K. Recruitment of P300/CPB in p53-dependent signal pathway. Cell 1997; 89: 1175-1184
20. Hemmati PG, Gillissen B, von Haefen C, Wendt J, Starck L, Guner D, Dorken B, Daniel PT. Adenovirus-mediated overexpression of P14(ARF) induces p53 and Bax-independent apoptosis. Oncogene 2002; 21: 3149-3161
21. Sturzenhofecker B, Schlott T, Quentin T, Kube D, Jung W, Trumper L. Abundant expression of spliced HDM2 in Hodgkin lymphoma cells does not interfere with p14(ARF) and p53 binding. Leuk Lymphoma 2003; 44: 1587-1596
22. Chen YN, Chen JC. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human Hepatoma cells. Int J Cancer 2002; 100: 158-165
23. Deng X, Kim M, Vandier D, Jung YJ, Rikiyama T, Sgagias MK, Goldsmith M, Cowan KH. Recombinant adenovirus-mediated p14(ARF) overexpression sensitixes human breast cancer cells to cisplatin. Biochem Biophys Res Commun 2002; 296: 792-798
24. Kasai H, Yamamoto K, Koseki T, Yokota M, Nishihara T. Involvement of caspase activation through release of cytochrome c from mitochondria in apoptotic cell death of macrophages infected with Actinobacillus actinomycetemcomitans. FEMS Microbiol Lett 2004; 233: 29-35
25. Tsujimoto Y. Cell death regulation by the Bcl-2 protein family in the mitochondria. J Cell Physiol 2003; 195: 158-167
26. Scorrano L, Korsmeyer SJ. Mechanisms of cytochrome c release by pro-apoptotic BCL-2 family members. Biochem Biophys Res Commun 2003; 304: 437-444
27. Ohtsuka T, Ryu H, Minamishima YA, Macip S, Sagara J, Nakayama KI, Aaronson SA, Lee SW. ASC is a Bax adaptor and regulates the p53-Bax mitochondrial apoptosis pathway. Nat Cell Biol 2004; 6 121-128
28. Pearson AS, Spitz FR, Swisher SG, Kataoka M, Sarkiss MG, Meyn RE, McDonnell TJ, Cristiano RJ, Roth JA. Upregulation of the proapoptotic mediators Bax and Bak after adenovirus-mediated p53 gene transfer in lung cancer cells. Clin Cancer Res 2000; 6: 887-890
29. Frederick MJ, Holton PR, Hudson M, Wang M, Clayman GL. Expression of apoptosis-related genes in human head and neck squamous cell carcinomas undergoing p53-mediated programmed cell death. Clin Cancer Res 1999; 5: 361-369
30. Mohiuddin I, Cao XB. Significant augmentation of proapoptotic gene therapy by pharmacologic bcl-xl down-regulation in mesochelioma. Cancer Gene Therapy 2001; 8: 547-554
31. Thomborrow EC, Manfredi JJ. The tumor suppressor protein p53 requires a cofactor to activate transcriptionally the human BAX promoter. J Biol Chem 2001; 276: 15598-15608
32. Srivastava M, Ahmad N, Gupta S, Mukhtar H. Involvement of Bcl-2 and Bax in photodynamic therapy-mediated apoptosis. Antisense Bcl-2 oligonucleotide sensitizes RIF 1 cells to photodynamic therapy apoptosis. J Biol Chem 2001; 276: 15481-15488
33. Ahn SG, Kim HS, Jeong SW, Kim BE, Rhim H, Shim JY, Kim JW, Lee JH, Kim IK. Sox-4 is positive regulator of Hep3B and HepG2 cells' apoptosis induced by prostaglandin (PG) A2 and delta (12)-PGJ2. Exp Mol Med 2002; 34: 243-249
34. Takehara T, Liu X, Fujimoto J, Friedman SL, Takahashi H. Expression and role of Bd-xL in human hepatocellular carcinomas. Hepatology 2001; 34: 55-61
35. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254
36. Chun E, Lee KY. Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cells. Biochem Biophys Res Commun 2004; 315: 771-779